Seaport Therapeutics Inc. Common Stock (SPTX)
Stock · NASDAQ · Health Care
$24.48as of 8/28/2026
Price chart
Open in TradingViewAbout SPTX
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety. The company's lead product candidate, GlyphAllo (SPT-300 or Glyph Allopregna…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 58
- Website
- seaporttx.com
Fundamentals
- 1-day range
- $23.26$24.48
- Market cap
- $1.24B
- P/E (trailing)
- —
- P/E (forward)
- -9.17
- EPS (trailing)
- $-2.52
- Dividend yield
- —
- Beta
- 0.21
- Avg. volume
- 198.0K
52-week range
$14.85$28.38
Forecasts
5 analyst ratings
Buy 82%
Hold 18%
Sell 0%
1-year price forecast
High
$50
+104.2%
Median
$35
+43.0%
Low
$30
+22.5%
Seaport Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SPTXSeaport Therapeutics Inc. Common Stock$24.04▼ 8.42%Market cap $1.24BP/E —$14.85$28.38
- MNKDMannKind Corporation Common Stock$3.96▼ 2.59%Market cap $1.24BP/E —$2.23$6.51
- ETONEton Pharmaceuticals Inc. Common Stock$59.79▼ 4.60%Market cap $1.26BP/E —$14.27$66.37
- ARDXArdelyx Inc. Common Stock$3.81▼ 0.26%Market cap $1.20BP/E —$3.73$8.4
- SVRASavara Inc. Common Stock$5.27▼ 4.10%Market cap $1.19BP/E —$3.19$7.01
- WVEWave Life Sciences Ltd. Ordinary Shares$5.04▼ 2.33%Market cap $1.19BP/E —$5.01$21.73
- CRVSCorvus Pharmaceuticals Inc. Common Stock$14.15▼ 3.87%Market cap $1.17BP/E —$5.28$26.95
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SPTX Seaport Therapeutics Inc. Common Stock | $1.24B | — | $24.04 | ▼ 8.42% | $14.85$28.38 |
| MNKD MannKind Corporation Common Stock | $1.24B | — | $3.96 | ▼ 2.59% | $2.23$6.51 |
| ETON Eton Pharmaceuticals Inc. Common Stock | $1.26B | — | $59.79 | ▼ 4.60% | $14.27$66.37 |
| ARDX Ardelyx Inc. Common Stock | $1.20B | — | $3.81 | ▼ 0.26% | $3.73$8.4 |
| SVRA Savara Inc. Common Stock | $1.19B | — | $5.27 | ▼ 4.10% | $3.19$7.01 |
| WVE Wave Life Sciences Ltd. Ordinary Shares | $1.19B | — | $5.04 | ▼ 2.33% | $5.01$21.73 |
| CRVS Corvus Pharmaceuticals Inc. Common Stock | $1.17B | — | $14.15 | ▼ 3.87% | $5.28$26.95 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Jones Trading Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $32benzinga · 8/26/2026
- HC Wainwright & Co. Reiterates Buy on Seaport Therapeutics, Maintains $50 Price TargetBenzinga · 8/20/2026
- Seaport Therapeutics: A Development-Arbitrage Platform With Two Layers Of ValidationSeekingAlpha · 8/11/2026
- Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) EstimateBenzinga · 8/3/2026
Insider Activity
Insider Actions →Acquired
16.45M
Disposed
51.63M
- Robert J. Hombach · June 22, 2026 · Buy13.0K @ $18.14
- PureTech Health plc · May 4, 2026 · Conversion3.03M
- PureTech Health plc · May 4, 2026 · Conversion8.42M
- PureTech Health plc · May 4, 2026 · Conversion40.00M
- PureTech Health plc · May 4, 2026 · Conversion965.3K
- PureTech Health plc · May 4, 2026 · Conversion2.68M
- PureTech Health plc · May 4, 2026 · Conversion12.74M
- Gladstein Lana · May 4, 2026 · Conversion105.3K
- Gladstein Lana · May 4, 2026 · Conversion33.5K
- Chen Michael Cunyuan · May 4, 2026 · Conversion10.5K
- Chen Michael Cunyuan · May 4, 2026 · Conversion3.4K
- White Lauren · May 4, 2026 · Conversion21.1K
- White Lauren · May 4, 2026 · Conversion6.7K
- Denice Torres · May 4, 2026 · Conversion42.1K
- Denice Torres · May 4, 2026 · Conversion13.4K
See the full, filterable feed with live charts on the MarketWall dashboard.